Content area

Abstract

SummaryBackground

Rapid, effective triage is integral to emergency cardiac care of patients with ST-elevation myocardial infarction (STEMI). Available models for predicting mortality in STEMI include up to 45 variables, but have consistently shown advanced age, increased heart rate, and decreased blood pressure to be among the strongest predictors.

Methods

On the basis of observed risk relations among 13 253 patients with STEMI from the InTIME II trial, we developed and assessed a simple risk index using age, heart rate, and systolic blood pressure (SBP) for predicting mortality over 30 days: (heart ratex[age/10]2)/SBP.

Findings

The risk index was a strong (c statistic=0·78) and independent predictor of mortality risk (p<0·0001). When the risk index was categorised into quintiles for convenient clinical use, it revealed a more than 20-fold gradient of increasing mortality from 0·8 to 17·4%, p<0·0001. The risk index was also a robust predictor of very early events, including death by 24 h (c statistic=0·81). External validation in patients with STEMI from the TIMI 9 trials (n=3659) showed both a high discriminatory capacity (c statistic=0·79), and excellent concordance between the observed 30-day mortality in each of the five risk groups and the predictions based on InTIME II (goodness-of-fit, p=0·7).

Interpretation

A simple risk index based on characteristics easily assessed by any paramedical or clinical personnel captures most of the information from more complex tools, and is likely to be useful in the rapid triage of patients with STEMI outside hospital or on first arrival in the hospital.

Details

Title
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy
Author
Morrow, David A 1 ; Antman, Elliott M 1 ; Giugliano, Robert P 1 ; Cairns, Richard 2 ; Charlesworth, Andrew 2 ; Murphy, Sabina A 3 ; de Lemos, James A 4 ; McCabe, Carolyn H 1 ; Braunwald, Eugene 1 

 TIMI Trials Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA 
 Nottingham Clinical Research, Nottingham, UK 
 Harvard Clinical Research Institute, Boston, MA, USA 
 Department of Medicine, University of Texas Southwestern, Dallas, TX, USA 
Pages
1571-1575
Section
Articles
Publication year
2001
Publication date
Nov 10, 2001
Publisher
Elsevier Limited
ISSN
01406736
e-ISSN
1474547X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2067776175
Copyright
Copyright Elsevier Limited Nov 10, 2001